Cargando…
Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGE(h)IV cohort participants
OBJECTIVES: Recent studies have reported disproportionate weight gain associated with integrase strand transfer inhibitor (INSTI) initiation in antiretroviral therapy(ART)-naive people with HIV (PWH), particularly among black women. We investigated if HIV-positive AGE(h)IV participants with suppress...
Autores principales: | Verboeket, Sebastiaan O., Boyd, Anders, Wit, Ferdinand W., Verheij, Eveline, Schim van der Loeff, Maarten F., Kootstra, Neeltje, van der Valk, Marc, Reiss, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099065/ https://www.ncbi.nlm.nih.gov/pubmed/33951089 http://dx.doi.org/10.1371/journal.pone.0251205 |
Ejemplares similares
-
Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8(+) T-Cell Counts and Lower CD4(+)/CD8(+) T-Cell Ratios Compared With HIV-Negative Heterosexual Men
por: Verboeket, Sebastiaan O, et al.
Publicado: (2020) -
Frequency, Risk Factors, and Mediators of Frailty Transitions During Long-Term Follow-Up Among People With HIV and HIV-Negative AGE(h)IV Cohort Participants
por: Verheij, Eveline, et al.
Publicado: (2021) -
One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor
por: Verburgh, Myrthe L, et al.
Publicado: (2022) -
Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)–Positive and HIV-Negative Participants
por: Verheij, Eveline, et al.
Publicado: (2020) -
No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain
por: Verburgh, Myrthe L., et al.
Publicado: (2023)